premenstrual syndrome. Other specified mood [affective] disorders
Conditions
Interventions
Intervention 1: Intervention group: Auriculotherapy is performed once a week for four weeks during a monthly menstrual cycle (except for seven days of menstrual bleeding), starting seven days before t
Sponsors
Torbate-Heidaria University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Presence of moderate to severe premenstrual syndrome according to the premenstrual syndrome instrument age 35-18 years Iranian nationality having regular menstrual cycles with equal intervals (22-35 days) no history of psychological diseases , chronic diseases and depression based on the DASS21 questionnaire no use of antidepressants, sedatives and hormonal drugs no mass, infection or scar on the external ear
Exclusion criteria
Exclusion criteria: pregnancy Diagnosis of secondary dysmenorrhea (due to causes such as cyst, fibroid or endometriosis) not attending all sessions Regular auriculotherapy (more than two absent sessions) failure to complete the premenstrual syndrome symptom registration table receiving another treatment method to improve premenstrual syndrome (medicine, herbal therapy, hormonal therapy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of premenstrual syndrome. Timepoint: Collecting information in four time stages: the beginning of the intervention (T1), after the first cycle of the intervention (fifth week) (T2), after the second cycle of the intervention (ninth week) (T3) and follow-up one month later in the 13th week after the start of the intervention (T4). Method of measurement: premenstrual syndrome screening questionnaire (PSST). | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: The beginning of the intervention (T1), after the first cycle of the intervention (fifth week) (T2), after the second cycle of the intervention (ninth week) (T3) and follow-up one month later in the 13th week after the start of the intervention (T4). Method of measurement: DASS21 questionnaire.;Quality of life. Timepoint: The beginning of the intervention (T1), after the first cycle of the intervention (fifth week) (T2), after the second cycle of the intervention (ninth week) (T3) and follow-up one month later in the 13th week after. Method of measurement: WHO-QOL questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Zahra Hoseini Haji
Torbate-Heidaria University of Medical Sciences
Outcome results
None listed